drugset / Trial / NCT01537614

Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis

NCT01537614

Phase 1 Completed 7 enrolled Poitiers University Hospital

Summary

Pharmacokinetics of colimycin will be assessed during 12 hours after administration of 2M UI colimycin either as an aerosol or after IV injection, the administration being separated by 5 to 10 days intervals

Timeline

Start
2011-10
Primary completion
2013-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Colistimethate Unknown 2 iu Inhaled

Indications